Amikacin
Amikacin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Amikacin sulfate indicated in the short-term treatment of serious infections due to susceptible organisms
- [With the exception of uncomplicated UTI, aminoglycosides are generally used in combination for treatment of Pseudomonas aeruginosa.]
- Bacterial septicemia (including neonatal sepsis)
- Respiratory tract infections
- Bones and joint infections
- Central nervous system infections
- Skin and soft tissue infections (including burns, post-operative infections)
- Intra-abdominal infections
- Complicated and recurrent urinary tract infections.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Pneumonia, Hospital-Acquired (in combination with a beta-lactam, beta-lactam/beta-lactamase inhibitor, or a third-/fourth-generation cephalosporin)
- Tuberculosis
- Non-tubercular mycobacterial (NTM) infections
- Nocardia
- Aerosolized amikacin has been used for the management of cystic fibrosis exacerbations
-- To view the remaining sections of this topic, please sign in or purchase a subscription --